Shon Lo

Shon Lo

McDermott Will & Emery

Contact  |  View Bio  |  RSS

Latest Publications

Share:

ANDA Update - March 2017 Volume 3, Number 1

Speculative Evidence of Irreparable Harm Sinks Bayer's Request for Permanent Injunction - Bayer Pharma AG, et al. v. Watson Laboratories, Inc. (D. Del. December 28, 2016) - Applying the eBay factors to Plaintiff...more

3/22/2017 - ANDA Bayer Class Action Depositions Divided Infringement FDA Inducement Method Claims Obviousness Patent Infringement Patent Litigation Patents Pay-For-Delay Permanent Injunctions Pharmaceutical Industry Pharmaceutical Patents Prior Art

US Supreme Court Rules Export of Single Component of Patented Combination Does Not Impose Liability under Section 271(f)(1)

On February 22, 2017, in reversing the decision of the US Court of Appeals for the Federal Circuit, an essentially unanimous US Supreme Court ruled that the “supply of a single component of a multi-component invention for...more

2/23/2017 - Life Technologies v Promega Patent Infringement Patent Litigation Patents Section 271

ANDA Update - Volume 2, Number 3

On-Sale Bar Is No Bar for Selling Manufacturing Services to the Inventor - Addressing what constitutes an invalidating “sale” under § 102(b), the US Court of Appeals for the Federal Circuit sitting en banc affirmed the...more

11/4/2016 - ANDA Antitrust Violations Appeals Direct Infringement FDA HIV Indirect Infringement Inventors Manufacturers Motion to Dismiss On-Sale Bar Patent Infringement Patent Litigation Patents Pharmaceutical Industry Product Hopping Reverse Payments Sherman Act

Inherent Disclosure Supplies Adequate Written Description for Priority Claim

Addressing the doctrine of inherent disclosure, the US Court of Appeals for the Federal Circuit held that a protein can satisfy the written description requirement when the priority application discloses only a partial amino...more

11/2/2016 - Appeals Board of Patent Appeals Inherent Disclosure Doctrine Patent Trial and Appeal Board Patents Priority Patent Claims Written Descriptions

Reformulated OxyContin Patents Invalid - Purdue Pharma L.P., et al. v. Epic Pharma, LLC, et al.

Addressing product-by-process limitations and inherent anticipation issues, the US Court of Appeals for the Federal Circuit affirmed the district court’s ruling that the asserted claims of Purdue Pharma’s patents covering...more

4/5/2016 - OxyContin Patent Invalidity Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs

Re-Exam Claiming Opposite Enantiomer Not Enough to Invalidate Patent (Cubist Pharmaceuticals, Inc. v. Hospira, Inc., (Fed. Cir....

The U.S. Court of Appeals for the Federal Circuit affirmed the judgment of the district court regarding the five asserted patents. Cubist Pharmaceuticals, Inc. v. Hospira, Inc., 805 F.3d 1112, 1115 (Fed. Cir. 2015)....more

3/8/2016 - Inter Partes Reexamination Obviousness Patent Infringement Patent Invalidity Patents Pharmaceutical Patents USPTO

Foreign Proceedings Do Not Trigger § 315(b) Time Bar - Micron Tech. Inc. v. Mass. Institute of Tech., et al.

Clarifying the meaning of “complaint” for purposes of the 35 U.S.C. § 315(b) one-year time bar for instituting an inter partes review (IPR), the Patent Trial and Appeal Board (PTAB or Board) concluded that a proceeding in a...more

1/7/2016 - § 315(b) Complaint Procedures Inter Partes Review (IPR) Proceeding International Litigation Patent Infringement Patent Trial and Appeal Board Patents Statute of Limitations

ANDA Update - July 2015

Supreme Court Holds Good Faith Belief of Patent Invalidity Is Not a Defense to Induced Infringement - Commil USA, LLC v. Cisco Systems, Inc. (Supr. Ct. May 26, 2015): Pharmaceutical patents commonly include...more

7/30/2015 - ANDA Cisco v CommilUSA Generic Drugs Hatch-Waxman Induced Infringement Noninfringement Patent Infringement Patent Invalidity Patents Pharmaceutical Patents SCOTUS

Statute Intended to Close Deepsouth Loophole Given Broad Interpretation - Promega Corp. v. Life Techs. Corp.

Addressing the requirements of infringement based on extraterritorial combinations of components, the U.S. Court of Appeals for the Federal Circuit reversed a lower court’s ruling of no infringement, finding that for a patent...more

2/10/2015 - DNA Induced Infringement Intellectual Property Litigation Patent Infringement Patent Litigation Patents

IP Update, Vol. 16, No. 6, June 2013

Patents / Patent Eligible Subject Matter - Supreme Court to Myriad: Isolated DNA Sequences Are Not Patent-Eligible Subject Matter -- AMP et al. v. Myriad Genetics, Inc.: In a 9–0 decision the Supreme...more

6/27/2013 - Abuse of Discretion AMP v Myriad Burden of Proof Copyright Damages DNA False Advertising First Amendment Human Genes Infringement Lanham Act Myriad Oprah Winfrey Patent Terms Patent-Eligible Subject Matter Patents Permanent Injunctions SCOTUS Time Warner Trade Secrets Trademarks USPTO Willful Infringement

IP Update, Vol. 16, No. 5, May 2013

Patent Exhaustion Rejected: Patented Seed Purchaser Has No Right to Make Copies: Bowman v. Monsanto Co. - In a narrow ruling that reaffirms the scope of patent protection over seeds, and possibly over other...more

5/31/2013 - Arbitration Bowman v Monsanto Claim Construction CLS Bank CLS Bank v Alice Corp Copyright FRAND Genetically Engineered Seed Infringement Monsanto Obviousness Patent Exhaustion Patents SCOTUS Standard Essential Patents Standing Trademarks

12 Results
|
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×